Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders
- PMID: 32443651
- PMCID: PMC7279050
- DOI: 10.3390/ijms21103576
Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders
Abstract
Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental conditions categorized as synaptopathies. Environmental risk factors contribute to ASD aetiology. In particular, prenatal exposure to the anti-epileptic drug valproic acid (VPA) may increase the risk of autism. In the present study, we investigated the effect of prenatal exposure to VPA on the synaptic morphology and expression of key synaptic proteins in the hippocampus and cerebral cortex of young-adult male offspring. To characterize the VPA-induced autism model, behavioural outcomes, microglia-related neuroinflammation, and oxidative stress were analysed. Our data showed that prenatal exposure to VPA impaired communication in neonatal rats, reduced their exploratory activity, and led to anxiety-like and repetitive behaviours in the young-adult animals. VPA-induced pathological alterations in the ultrastructures of synapses accompanied by deregulation of key pre- and postsynaptic structural and functional proteins. Moreover, VPA exposure altered the redox status and expression of proinflammatory genes in a brain region-specific manner. The disruption of synaptic structure and plasticity may be the primary insult responsible for autism-related behaviour in the offspring. The vulnerability of specific synaptic proteins to the epigenetic effects of VPA may highlight the potential mechanisms by which prenatal VPA exposure generates behavioural changes.
Keywords: autism spectrum disorders (ASD); microglia; neuroinflammation; oxidative stress; pre- and postsynaptic proteins; synaptic ultrastructure; synaptopathology; valproic acid (VPA).
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
Similar articles
-
Hippocampal neurons isolated from rats subjected to the valproic acid model mimic in vivo synaptic pattern: evidence of neuronal priming during early development in autism spectrum disorders.Mol Autism. 2021 Mar 6;12(1):23. doi: 10.1186/s13229-021-00428-8. Mol Autism. 2021. PMID: 33676530 Free PMC article.
-
Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.Brain Res Bull. 2019 Apr;147:36-46. doi: 10.1016/j.brainresbull.2019.02.003. Epub 2019 Feb 12. Brain Res Bull. 2019. PMID: 30769127
-
Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.Sci Rep. 2021 Dec 6;11(1):23471. doi: 10.1038/s41598-021-02994-6. Sci Rep. 2021. PMID: 34873263 Free PMC article.
-
Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment.Biomed Pharmacother. 2021 May;137:111322. doi: 10.1016/j.biopha.2021.111322. Epub 2021 Feb 16. Biomed Pharmacother. 2021. PMID: 33761592 Review.
-
Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder.Neuropharmacology. 2019 Nov 15;159:107477. doi: 10.1016/j.neuropharm.2018.12.024. Epub 2019 Jan 9. Neuropharmacology. 2019. PMID: 30639388 Review.
Cited by
-
Gestational hypothyroxinemia induces ASD-like phenotypes in behavior, proinflammatory markers, and glutamatergic protein expression in mouse offspring of both sexes.Front Endocrinol (Lausanne). 2024 May 1;15:1381180. doi: 10.3389/fendo.2024.1381180. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38752179 Free PMC article.
-
Insights into the structure and function of the hippocampus: implications for the pathophysiology and treatment of autism spectrum disorder.Front Psychiatry. 2024 Apr 23;15:1364858. doi: 10.3389/fpsyt.2024.1364858. eCollection 2024. Front Psychiatry. 2024. PMID: 38716113 Free PMC article. Review.
-
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder.Curr Neuropharmacol. 2024;22(2):260-289. doi: 10.2174/1570159X22666231003121513. Curr Neuropharmacol. 2024. PMID: 37873949 Free PMC article. Review.
-
Alterations of Purinergic Receptors Levels and Their Involvement in the Glial Cell Morphology in a Pre-Clinical Model of Autism Spectrum Disorders.Brain Sci. 2023 Jul 18;13(7):1088. doi: 10.3390/brainsci13071088. Brain Sci. 2023. PMID: 37509018 Free PMC article.
-
Microtubule Cytoskeletal Network Alterations in a Transgenic Model of Tuberous Sclerosis Complex: Relevance to Autism Spectrum Disorders.Int J Mol Sci. 2023 Apr 15;24(8):7303. doi: 10.3390/ijms24087303. Int J Mol Sci. 2023. PMID: 37108467 Free PMC article.
References
-
- Safari M.R., Omrani M.D., Noroozi R., Sayad A., Sarrafzadeh S., Komaki A., Manjili F.A., Mazdeh M., Ghaleiha A., Taheri M. Synaptosome-Associated Protein 25 (SNAP25) Gene Association Analysis Revealed Risk Variants for ASD, in Iranian Population. J. Mol. Neurosci. 2017;61:305–311. doi: 10.1007/s12031-016-0860-2. - DOI - PubMed
-
- Baio J., Wiggins L., Christensen D.L., Maenner M.J., Daniels J., Warren Z., Kurzius-Spencer M., Zahorodny W., Robinson Rosenberg C., White T., et al. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years -Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. MMWR Surveill Summ. 2018;67:1–23. doi: 10.15585/mmwr.ss6706a1. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical